ConductScience.org, home

Paper32099367

Neuroprotective effect and mechanism of baicalin on Parkinson's disease model induced by 6-OHDA.

Tu L and 9 others. Neuropsychiatr Dis Treat, 2019. Cited by 22 papers, by iCite.

Cite this record

ConductScience Library. Neuroprotective effect and mechanism of baicalin on Parkinson's disease model induced by 6-OHDA. Papers, record 32099367. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32099367

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Neuroprotective effect and mechanism of baicalin on Parkinson's disease model induced by 6-OHDA.
PubMed
Journal
Neuropsychiatr Dis Treat
PubMed
Year
2019
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
22
iCite
Relative citation ratio, by iCite
1.43
iCite
Revised in PubMed
2022-04-13
PubMed

Authors10

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Tu LLi
2Wu ZYZhuo-Yu
3Yang XLXiu-Lin
4Zhang QQian
5Gu RRan
6Wang QQian
7Tian TTian
8Yao HHuan
9Qu XXiang
10Tian JYJin-Yong

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References33

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
123573240Therapeutic effect of hydrogen sulfide-releasing L-Dopa derivative ACS84 on 6-OHDA-induced Parkinson's disease rat model.PLoS One2013https://conductscience.org/library/papers/23573240PubMed
222711560An in vivo ultrahigh field 14.1 T (1) H-MRS study on 6-OHDA and α-synuclein-based rat models of Parkinson's disease: GABA as an early disease marker.NMR Biomed2013https://conductscience.org/library/papers/22711560PubMed
324642369Neuroprotective effect of curcumin on hippocampal injury in 6-OHDA-induced Parkinson's disease rat.Pathol Res Pract2014https://conductscience.org/library/papers/24642369PubMed
425558221Baicalin and deferoxamine alleviate iron accumulation in different brain regions of Parkinson's disease rats.Neural Regen Res2012https://conductscience.org/library/papers/25558221PubMed
528849467Metabolomics Profiling of the Effects of Taurine Supplementation on Dyslipidemia in a High-Fat-Diet-Induced Rat Model by 1H NMR Spectroscopy.Adv Exp Med Biol2017https://conductscience.org/library/papers/28849467PubMed
625206866Baicalin suppresses iron accumulation after substantia nigra injury: relationship between iron concentration and transferrin expression.Neural Regen Res2014https://conductscience.org/library/papers/25206866PubMed
729454627Changes in salsolinol production and salsolinol synthase activity in Parkinson's disease model.Neurosci Lett2018https://conductscience.org/library/papers/29454627PubMed
819425176Brain oxidative stress and selective behaviour of aluminium in specific areas of rat brain: potential effects in a 6-OHDA-induced model of Parkinson's disease.J Neurochem2009https://conductscience.org/library/papers/19425176PubMed
921093517Neuroprotective effects of SCM198 on 6-hydroxydopamine-induced behavioral deficit in rats and cytotoxicity in neuronal SH-SY5Y cells.Neurochem Int2011https://conductscience.org/library/papers/21093517PubMed
1026758268Heat shock protein 60 affects behavioral improvement in a rat model of Parkinson's disease grafted with human umbilical cord mesenchymal stem cell-derived dopaminergic-like neurons.Neurochem Res2016https://conductscience.org/library/papers/26758268PubMed
1125766133Alteration of enteric monoamines with monoamine receptors and colonic dysmotility in 6-hydroxydopamine-induced Parkinson's disease rats.Transl Res2015https://conductscience.org/library/papers/25766133PubMed
12258493231H NMR-based metabolomics investigation of copper-laden rat: a model of Wilson's disease.PLoS One2015https://conductscience.org/library/papers/25849323PubMed
1327338353Neuroprotective and Therapeutic Strategies against Parkinson's Disease: Recent Perspectives.Int J Mol Sci2016https://conductscience.org/library/papers/27338353PubMed
1425781584The effects of cognitive reserve and lifestyle on cognition and dementia in Parkinson's disease--a longitudinal cohort study.Int J Geriatr Psychiatry2016https://conductscience.org/library/papers/25781584PubMed
1517080509Determination of dopamine and its relativity of baicalin in rat nuclei after intravenous administration of flavonoids from Scutellariae radix.Biomed Chromatogr2007https://conductscience.org/library/papers/17080509PubMed
1618173149[Protective effect of baicalin on mouse with Parkinson's disease induced by MPTP].Zhongguo Zhong Xi Yi Jie He Za Zhi2007https://conductscience.org/library/papers/18173149PubMed
1725781638Study of the cardiotoxicity of Venenum Bufonis in rats using an 1H NMR-based metabolomics approach.PLoS One2015https://conductscience.org/library/papers/25781638PubMed
1826172319Alterations in the motor cortical and striatal glutamatergic system and D-serine levels in the bilateral 6-hydroxydopamine rat model for Parkinson's disease.Neurochem Int2015https://conductscience.org/library/papers/26172319PubMed
1925499317Effects of endogenous melatonin on glutamate and GABA rhythms in the striatum of unilateral 6-hydroxydopamine-lesioned rats.Neuroscience2015https://conductscience.org/library/papers/25499317PubMed
2026236101Metabolomics changes in a rat model of obstructive jaundice: mapping to metabolism of amino acids, carbohydrates and lipids as well as oxidative stress.J Clin Biochem Nutr2015https://conductscience.org/library/papers/26236101PubMed

See all 33 referencesDownload CSV of references

Cited by16

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 22 citations.

PMIDTitleJournalYearIn PapersSource
42653806Pathogenesis-Driven Drug Repurposing with a Self-Nanoemulsifying Delivery System for Parkinson's Disease.Pharmaceuticals (Basel)2026https://conductscience.org/library/papers/42653806PubMed
42633185Baicalin and CNS-related diseases: new insights into neuroprotective potentials based on underlying mechanisms.Biochem Biophys Rep2026https://conductscience.org/library/papers/42633185PubMed
42133065Baicalin: A comprehensive review of its molecular mechanisms and pharmacological activities.Naunyn Schmiedebergs Arch Pharmacol2026https://conductscience.org/library/papers/42133065PubMed
41023471Potential new drug sources for the treatment of Parkinson's disease: flavonoid O-glycosides.Mol Biol Rep2025https://conductscience.org/library/papers/41023471PubMed
40932545Baicalin: bridging traditional medicine and modern science in food and functional applications.Naunyn Schmiedebergs Arch Pharmacol2026https://conductscience.org/library/papers/40932545PubMed
40868260An Overview of the Role of Medicinal Plants in Parkinson's Disease: A Semi-Systematic Review.Biomedicines2025https://conductscience.org/library/papers/40868260PubMed
39758400Neuroprotective effects of baicalin and baicalein on the central nervous system and the underlying mechanisms.Heliyon2025https://conductscience.org/library/papers/39758400PubMed
39687298Mitigating neurodegenerative diseases: the protective influence of baicalin and baicalein through neuroinflammation regulation.Front Pharmacol2024https://conductscience.org/library/papers/39687298PubMed
38992324Crosstalk between gut-brain axis: unveiling the mysteries of gut ROS in progression of Parkinson's disease.Inflammopharmacology2024https://conductscience.org/library/papers/38992324PubMed
37764277Therapeutic Effects of Baicalin on Diseases Related to Gut-Brain Axis Dysfunctions.Molecules2023https://conductscience.org/library/papers/37764277PubMed
36865047Protective effects of baicalin against L-glutamate-induced oxidative damage in HT-22 cells by inhibiting NLRP3 inflammasome activation via Nrf2/HO-1 signaling.Iran J Basic Med Sci2023https://conductscience.org/library/papers/36865047PubMed
35676380Scutellaria baicalensis and its constituents baicalin and baicalein as antidotes or protective agents against chemical toxicities: a comprehensive review.Naunyn Schmiedebergs Arch Pharmacol2022https://conductscience.org/library/papers/35676380PubMed
35646277Baicalin provides protection against fluoxetine-induced hepatotoxicity by modulation of oxidative stress and inflammation.World J Hepatol2022https://conductscience.org/library/papers/35646277PubMed
35144603Thymol protects against 6-hydroxydopamine-induced neurotoxicity in in vivo and in vitro model of Parkinson's disease via inhibiting oxidative stress.BMC Complement Med Ther2022https://conductscience.org/library/papers/35144603PubMed
33891262Baicalin and Geniposide Inhibit Polarization and Inflammatory Injury of OGD/R-Treated Microglia by Suppressing the 5-LOX/LTB4 Pathway.Neurochem Res2021https://conductscience.org/library/papers/33891262PubMed
33247801Idebenone Ameliorates Rotenone-Induced Parkinson's Disease in Rats Through Decreasing Lipid Peroxidation.Neurochem Res2021https://conductscience.org/library/papers/33247801PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/32099367

GET https://conductscience.org/api/papers/v1/32099367/references?page=2